Fermenta Biotech subsidiary FESPL to issue shares to Aasava

1 min read     Updated on 20 Jul 2026, 05:57 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Fermenta Biotech Limited's subsidiary, FESPL, entered into a share subscription agreement with Aasava Management Services LLP on July 20, 2026, to issue 7,17,949 equity shares for ₹86,15,388. This investment will reduce Fermenta Biotech's stake to 91.76%, causing FESPL to cease being a wholly-owned subsidiary. FESPL reported a revenue of ₹400.53 lakhs and a net worth of ₹340.24 lakhs for the financial year ended March 31, 2026.

powered bylight_fuzz_icon
46096014

*this image is generated using AI for illustrative purposes only.

Fermenta Biotech Limited announced that its subsidiary, Fermenta Environment Solutions Private Limited (FESPL), will cease to be a wholly-owned subsidiary following a share subscription agreement with Aasava Management Services LLP. The agreements, signed on July 20, 2026, involve the issuance of 7,17,949 equity shares in FESPL to Aasava for a total subscription amount of ₹86,15,388. This strategic move is expected to be value accretive for FESPL and aligns the interests of Aasava, a long-time marketing associate and consultant, with the subsidiary's growth.

Post-allotment, Fermenta Biotech will retain a 91.76% shareholding in FESPL. The transaction is not classified as a slump sale or a related party transaction, and FESPL does not qualify as an 'Undertaking' under Section 180 of the Companies Act, 2013, or Regulation 37A of the SEBI Listing Regulations. The investment by Aasava reflects confidence in the environment solutions business and its expansion strategy.

The subsidiary was incorporated on May 1, 2025. According to the audited financial statements as on March 31, 2026, FESPL reported a total revenue of ₹400.53 lakhs, which accounted for 0.73% of Fermenta Biotech's consolidated figures. The net worth of FESPL stood at ₹340.24 lakhs, representing 0.85% of the consolidated net worth of the parent company.

The allotment of equity shares to Aasava is anticipated to be completed by or before July 27, 2026. No consideration will be received by Fermenta Biotech from this transaction, as the subscription amount is payable directly to FESPL. Aasava Management Services LLP is registered under the Limited Liability Partnership Act, 2008, and is not part of the promoter or promoter group of Fermenta Biotech.

Key Financials of FESPL

Metric Amount % of Consolidated Figures
Total Revenue (FY26) ₹400.53 lakhs 0.73%
Net Worth (as on March 31, 2026) ₹340.24 lakhs 0.85%

Transaction Details

Particular Details
Shares Issued 7,17,949 equity shares
Subscription Amount ₹86,15,388
Expected Allotment Date July 27, 2026
Parent Stake Post-Allotment 91.76%

Historical Stock Returns for Fermenta Biotech

1 Day5 Days1 Month6 Months1 Year5 Years
-1.86%-2.11%+27.16%+36.82%+36.82%+36.82%

How will the infusion of ₹86.15 lakhs specifically be utilized by FESPL to scale its environment solutions operations?

Does this strategic partnership with Aasava signal a shift in Fermenta Biotech's strategy towards diversifying its revenue streams?

What are the projected revenue contributions of FESPL to the consolidated financials over the next 3-5 years?

Fermenta Biotech to host investor meet on July 23, 2026

0 min read     Updated on 17 Jul 2026, 05:56 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Fermenta Biotech Limited will hold a one-to-one meeting with investors on July 23, 2026, in Mumbai, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that relevant press releases and investor presentations are available on its website and the BSE Limited website, and no unpublished price sensitive information (UPSI) is intended to be shared. Changes to the schedule may occur due to exigencies on the part of the company or the investors.

powered bylight_fuzz_icon
45836446

*this image is generated using AI for illustrative purposes only.

Fermenta Biotech Limited will hold a one-to-one meeting with investors on July 23, 2026, in Mumbai. The interaction is being conducted pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company stated that relevant press releases and investor presentations proposed for discussion are available on its website and the BSE Limited website. Fermenta Biotech clarified that no unpublished price sensitive information (UPSI) is intended to be shared during the meeting.

Date Type of meeting Mode Location
July 23, 2026 One-to-one meeting Physical Mumbai

Changes to the schedule may occur due to exigencies on the part of the company or the investors.

Historical Stock Returns for Fermenta Biotech

1 Day5 Days1 Month6 Months1 Year5 Years
-1.86%-2.11%+27.16%+36.82%+36.82%+36.82%

What strategic topics are likely to dominate the investor meeting?

How might the meeting influence Fermenta Biotech's stock performance?

Could the meeting signal upcoming corporate developments or partnerships?

More News on Fermenta Biotech

1 Year Returns:+36.82%